Brand names: Ozempic (weekly injection, diabetes-approved), Wegovy (weekly injection, higher dose, weight-management specific), Rybelsus (once-daily oral tablet)
Ronkainen, J
Introduction Irritable bowel syndrome (IBS) is a prevalent and debilitating gastrointestinal condition characterized by recurrent flare-ups of symptoms such as increased central pain, bloating, diarrhea, and constipation ( Post-viral gastroenteritis, pre-morbid psychological disorders, and the hypothalamic-pituitary-adrenal axis mediate a maladaptive stress response, which is essential for the onset, intensity, and persistence of IBS-associated symptoms ( The Rome IV diagnostic criteria are currently used to diagnose IBS, which is divided into four subgroups based on bowel habits, bowel function, and stool consistency: constipation dominant (IBS-C), diarrhea dominant (IBS-D), mixed (IBS-M), and unclassified/unspecified IBS (IBS-U) ( Following food consumption, the metabolic endocrine cascade begins with gastric emptying
COA and HPLC for SLU-PP-332 and 5-Amino-1MQ Quality is key when researching with compounds like SLU-PP-332 and 5-Amino-1MQ
The 2026 narrative review found vitamin D deficiency in 7.5% of patients at 6 months and 13.6% at 12 months